NCT06911424 - Efficacy of Fusidic Acid 1% in the Treatment of Bacterial Conjunctivitis | Biotech Hunter

Enrollment

400

Participants

Timeline

Start Date

March 21, 2025

Primary Completion Date

December 15, 2025

Study Completion Date

December 22, 2025

Conditions

Bacterial Conjunctivitis

Interventions

DRUG

Fusidic Acid 1%

Fusidic acid 1%

DRUG

Placebo

Placebo ophthalmic solution

Trial Locations (27)

11702

RECRUITING

Baxis Site 23, Babylon

15227

WITHDRAWN

Baxis Site 09, Pittsburgh

21045

RECRUITING

Baxis Site 26, Columbia

27030

RECRUITING

Baxis Site 05, Mount Airy

29414

RECRUITING

Baxis Site 12, Charleston

33014

RECRUITING

Baxis Site 28, Miami Lakes

33140

RECRUITING

Baxis Site 13, Miami Beach

33155

RECRUITING

Baxis Site 01, Miami

33172

RECRUITING

Baxis Site 22, Doral

33176

TERMINATED

Baxis Site 03, Miami

33460

RECRUITING

Baxis Site 11, Lake Worth

33549

RECRUITING

Baxis Site 27, Lutz

33613

RECRUITING

Baxis Site 10, Tampa

60462

RECRUITING

Baxis Site 06, Orland Park

72205

RECRUITING

Baxis Site 04, Little Rock

74133

RECRUITING

Baxis Site 25, Tulsa

77338

RECRUITING

Baxis Site 02, Humble

77345

RECRUITING

Baxis Site 14, Kingwood

78539

RECRUITING

Baxis Site 08, Edinburg

83404

RECRUITING

Baxis Site 15, Idaho Falls

84041

RECRUITING

Baxis Site 17, Layton

RECRUITING

Baxis Site 18, Layton

84120

RECRUITING

Baxis Site 16, West Valley City

89030

RECRUITING

Baxis Site 21, North Las Vegas

91423

RECRUITING

Baxis Site 20, Sherman Oaks

92037

RECRUITING

Baxis Site 19, La Jolla

92647

RECRUITING

Baxis Site 24, Huntington Beach